Association between multi-dose drug dispensing and quality of drug treatment--a register-based study

Christina Sjöberg1, Christina Edward, Johan Fastbom

  • 1Department of Geriatrics, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden. christina.a.sjoberg@vgregion.se

Plos One
|November 9, 2011
PubMed
Abstract

Insights

Multi-dose drug dispensing (MDD) in elderly patients is linked to poorer drug treatment quality compared to ordinary prescriptions (OP). These findings highlight potential issues with MDD systems that require further investigation.

Area of Science:

  • Geriatric Pharmacy
  • Pharmacoeconomics
  • Health Services Research

Background:

  • Multi-dose drug dispensing (MDD) is a prevalent alternative to ordinary prescriptions (OP) for elderly patients in Scandinavia.
  • MDD involves dispensing medications in unit bags for each dose, differing in prescribing procedures from OP.

Purpose of the Study:

  • To investigate the association between multi-dose drug dispensing (MDD) and the quality of drug treatment (QDT) in elderly patients.
  • To determine if differences in QDT between MDD and OP are attributable to patient demographics or disease burden.

Main Methods:

  • A cross-sectional study analyzed data from 24,146 elderly patients (≥65 years) in Region Västra Götaland.
  • Quality of drug treatment (QDT) was assessed using established indicators, including polypharmacy and use of specific drug classes.
  • Logistic regression adjusted for age, sex, disease burden, and residence was used to compare QDT between MDD and OP groups.

Main Results:

  • Patients utilizing MDD (20% of the cohort) exhibited significantly poorer QDT across all evaluated indicators compared to those on OP (P<0.0001).
  • Unadjusted and adjusted odds ratios indicated a substantially higher likelihood of poor QDT for MDD patients, ranging from 1.36 to 5.48.
  • These associations persisted after controlling for patient age, sex, disease burden, and place of residence.

Conclusions:

  • Elderly patients using MDD demonstrate poorer quality of drug treatment than those on OP, irrespective of demographic factors or disease severity.
  • The findings underscore the need to consider these quality deficits when developing or refining drug dispensing systems.
  • Further research is warranted to identify causative factors and assess the generalizability of these results to other dispensing models.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...